deltatrials

Myelodysplastic syndromes Trials in St. Louis, United States

Conditions / Myelodysplastic syndromes / St. Louis, United States

Myelodysplastic syndromes is a medical condition with active clinical research programs worldwide.

72 total trials for this combination

Showing top 10 of 72 trials

Trials

NCT ID Title Status Phase
NCT00003593 Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome COMPLETED PHASE3
NCT00053196 Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer COMPLETED PHASE2
NCT03904134 Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) COMPLETED NA
NCT04904588 HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide ACTIVE_NOT_RECRUITING PHASE2
NCT00028899 Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes COMPLETED PHASE1
NCT06001385 HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis ACTIVE_NOT_RECRUITING PHASE2
NCT00003793 Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma COMPLETED
NCT00066248 Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment COMPLETED PHASE2
NCT00719563 American Ginseng in Treating Patients With Fatigue Caused by Cancer COMPLETED PHASE3
NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry RECRUITING

Related Pages